FDA warning letters
A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.
20 letters match. Newest first.
-
DevicesKoven Technologies, Inc.
FDA warns Koven Technologies that its Bidop 3 Doppler was labeled for fetal use without clearance and had quality system violations.
High risk -
DevicesDiasol, Inc.
Diasol sold unapproved citric acid hemodialysis disinfectants and had quality system violations, FDA says.
High risk -
DevicesLes Encres LLC
FDA warns Les Encres that its PDO surgical suture threads were promoted for unapproved cosmetic uses and had quality system violations.
High risk -
DevicesExer Labs, Inc.
Exer Labs marketed its Exer Scan device for AI diagnosis and treatment without FDA approval or clearance and lacked quality procedures.
High risk -
DevicesRed Oak Instruments, LLC
Red Oak Instruments marketed RU-Fit dynamometer for concussion screening without FDA clearance and had MDR and quality system violations.
High risk -
DevicesQ’Apel Medical, Inc.
Q’Apel Medical marketed an uncleared modified HIPPO stroke aspiration device and had quality system violations, FDA says.
High risk -
DevicesRobbins Instruments, LLC
Robbins Instruments marketed Dermo-Jet Needleless Injector without FDA clearance and had quality system violations.
High risk -
DevicesXoran Technologies, LLC
FDA warned Xoran Technologies that its computed tomography devices and software violate quality rules and lack required marketing clearance.
High risk -
DevicesP.T. Sankei Medical Industries
FDA warned P.T. Sankei Medical Industries over unapproved changes to its single-use sphygmomanometer and quality system violations.
High risk -
DevicesFuture Diagnostics Solutions B.V.
FDA cites Future Diagnostics over quality-system and reporting failures for STAT IntraOperative Intact PTH immunoassay kits.
High risk -
DevicesDr. Joel Kaplan Inc.
FDA warned Dr. Joel Kaplan Inc. that its sexual health devices are unapproved, misbranded, and made under quality system violations.
High risk -
DevicesDeymed Diagnostic s.r.o.
Deymed Diagnostic s.r.o.'s BrainFeedback Pro, TruScan LT, and DuoMAG NL devices had quality system violations in design, complaints, production, and records.
Medium -
DevicesNeurotris, Inc. dba A1 Engineering
FDA warns Neurotris over unapproved, misbranded facial/body stimulator devices and quality system violations.
High risk -
DevicesAbiomed Inc.
Abiomed marketed Impella Connect System without PMA and had CGMP, complaint, and MDR reporting failures.
High risk -
DevicesEmpowered Diagnostics LLC
Empowered Diagnostics distributed COVID-19 test kits without FDA approval or emergency authorization, and some labeling falsely said they were authorized.
High risk -
DevicesUnimicro Medical Systems-Shenzhen Co., Ltd.
FDA warns Shenzhen maker of Veress needles that quality system violations make its devices adulterated and subject to U.S. import detention.
High risk -
DevicesCardioQuip, LLC
CardioQuip sold significantly modified cardiac heater-cooler devices without required FDA clearance and with quality system violations.
High risk -
DevicesDeVilbiss Healthcare LLC
FDA cites DeVilbiss over oxygen concentrator overheating and late medical device reports.
High risk -
DevicesSmiths Medical ASD Inc.
FDA cites Smiths Medical for unreported Medfusion pump malfunctions and quality-system failures at its Minneapolis facility.
High risk -
DevicesInnova Medical Group, Inc.
Innova Medical Group distributed unapproved COVID-19 antigen tests and had quality-system and labeling violations, FDA says.
High risk